Sturnam
Bluelighter
- Joined
- Aug 12, 2008
- Messages
- 738
I recently came across a study listed on MAPS about MDE. It was about the subjective effects of the R and S enantomers, as well how the fMRI imaging of each.
As far as subjective effects, they found that:
Anyways, the point of their study was that the S enantomer was mainly responsible for the empathogenic effects, and R was responsible for the neurotoxic effects.
Does anyone know of any other studies of this nature, maybe on MDMA? I'm also interested in how the S enantomer of MDMA differs subjectively from the racemate. There are only a few reports in PiHKAL, and the only other thing I could find with some brief searching was Shulgin saying that neither isomer produced the magic.
Is it possible that the R-MDxx preferentially turns into toxic metabolites, or creates ROS?
Oh, and here's the source for that article:
Spitzer M, Franke B, Walter H, Buechler J, Wunderlich AP, Schwab M, Kovar K, Hermle L, Gron G (2001) Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans. Neuropharmacology 41: 263-71.
edit::
Found a study dealing with the different isomers of both MDA and MDMA. Unfortunately they use detro/levo to describe their results, and I'm not completely sure how to translate D/L into R/S, so if someone knows which is which, it would be a big help in interpreting these studies. However, they say that D-MDA is more stimulative, which leads to believe that it's the same as S-MDA. Can anyone confirm this?
Anyways, on to results:
- D-MDA has more of an effect on neurotransmitters than L-MDA, but this is lost at high doses
- D-MDMA has more of an effect on neurotransmitters, but only at high doses
- L-MDMA is more potent than D-MDMA at decreasing neostriatal 5-HT concentrations 3h after a single dose
- they hypothesize that both D-MDA and D-MDMA induce greater changes associated with neurotoxic properties
M Johnson, AA Letter, K Merchant, GR Hanson, and JW Gibb (1998). Effects of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat
J Pharmacol Exp. Ther. 244: 977-982.
As far as subjective effects, they found that:
Taken together, the (S)-enantiomer produced the entactogenic subjective effects of increased talkativeness, openness, and elevated mood whereas the (R)-enantiomer mainly caused dysphoria and somatic complaints.
Anyways, the point of their study was that the S enantomer was mainly responsible for the empathogenic effects, and R was responsible for the neurotoxic effects.
With respect to the neurotoxic effects of substituted
amphetamines, our data favour the (R)-enantiomer as a
possible candidate for the following reasons. This
enantiomer acts upon visual cortical areas into which the
5-HT system preferentially projects. This is in line with a
previous single-photon emission computed tomography
study demonstrating 5-HT related effects to be promi-
nent in the visual cortex of abstinent MDMA users
(Chang et al., 2000). In addition, the (R)-enantiomer
affects cortical areas relevant for carrying out those cog-
nitive functions that have been found to be impaired after
excessive abuse of MDMA, possibly by causing 5-HT
depletion after increased activity of these regions.
Finally, the approximately three-fold plasma concen-
trations of (R)-MDE alone would render this enantiomer
as the likely candidate for any neurotoxic effects.
Together with the differential psychological effects of
the agent, this suggests that any future medical appli-
cations of MDE within the framework of psychothera-
peutic interventions should make use of the (S)-enanti-
omer only.
Does anyone know of any other studies of this nature, maybe on MDMA? I'm also interested in how the S enantomer of MDMA differs subjectively from the racemate. There are only a few reports in PiHKAL, and the only other thing I could find with some brief searching was Shulgin saying that neither isomer produced the magic.
Is it possible that the R-MDxx preferentially turns into toxic metabolites, or creates ROS?
Oh, and here's the source for that article:
Spitzer M, Franke B, Walter H, Buechler J, Wunderlich AP, Schwab M, Kovar K, Hermle L, Gron G (2001) Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans. Neuropharmacology 41: 263-71.
edit::
Found a study dealing with the different isomers of both MDA and MDMA. Unfortunately they use detro/levo to describe their results, and I'm not completely sure how to translate D/L into R/S, so if someone knows which is which, it would be a big help in interpreting these studies. However, they say that D-MDA is more stimulative, which leads to believe that it's the same as S-MDA. Can anyone confirm this?
Anyways, on to results:
- D-MDA has more of an effect on neurotransmitters than L-MDA, but this is lost at high doses
- D-MDMA has more of an effect on neurotransmitters, but only at high doses
- L-MDMA is more potent than D-MDMA at decreasing neostriatal 5-HT concentrations 3h after a single dose
- they hypothesize that both D-MDA and D-MDMA induce greater changes associated with neurotoxic properties
M Johnson, AA Letter, K Merchant, GR Hanson, and JW Gibb (1998). Effects of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine isomers on central serotonergic, dopaminergic and nigral neurotensin systems of the rat
J Pharmacol Exp. Ther. 244: 977-982.
Last edited:
